SEC Form 4 · accession 0001228924-17-000001
MESA LABORATORIES INC /CO/ · MLAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn E Adriance
Officer — CSMO
Period of report
Feb 6, 2017
Accepted (ET)
Feb 7, 2017 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000724004
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2017 | M | 1,070 | $70.56 | A | 15,170 | D | |
| Common Stock | Feb 7, 2017 | S | 1,070 | $121.65 | D | 14,100 | D | |
| Common Stock | Feb 6, 2017 | S | 4,375 | $125.38 | D | 9,725 | D | |
| Common Stock | Feb 7, 2017 | S | 2,625 | $123.12 | D | 7,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock OptionF1 | $70.56 | Feb 6, 2017 | X | 871 | D | Apr 1, 2016 | Apr 1, 2023 | Common Stock | 871 | 20,837 | D |
| Incentive Stock OptionF1 | $70.56 | Feb 6, 2017 | X | 199 | D | Apr 1, 2016 | Apr 1, 2023 | Common Stock | 199 | 20,638 | D |
Explanation of responses
- F11/7 exercisable on each anniversary date